Documents 1 FDA Review of DASATINIB Oncology Drug Advisory Committee (ODAC) June 2, 2006.

FDA Review of DASATINIB Oncology Drug Advisory Committee (ODAC) June 2, 2006 Review teams Clinical - Michael Brave, M.D., Vicki Goodman, M.D., Edvardas Kaminskas, M.D., Ann…